“The Cannabis Use Disorder market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Cannabis Use Disorder pipeline products will significantly revolutionize the Cannabis Use Disorder market dynamics”
The Cannabis Use Disorder market report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM Cannabis Use Disorder market size from 2019 to 2032. The report also covers current Cannabis Use Disorder treatment practices/algorithms and unmet medical needs to curate the best opportunities and assess the market’s underlying potential.
Key Takeaways from the Cannabis Use Disorder Market Report
- The increase in Cannabis Use Disorder market size is a direct consequence of increasing prevalence of Cannabis Use Disorder (CUD) and the awareness to de-addict the youth, across the 7MM.
- According to DelveInsight’s analysis, Cannabis Use Disorder is more prevalent in males as compared to females.
- The leading Cannabis Use Disorder Companies working in the market include Indivior, Aelis Farma, PleoPharma Inc., Tilray, Fenix Innovation Group, Neurotech International, BrosMed Medical Co. Ltd., Klein Buendel Inc., and others.
- Promising Cannabis Use Disorder Pipeline Therapies in the various stages of development include AEF0117, FEN164, Brexpiprazole, MediCabilis CBD Oil, Cannabidiol (CBD) Oil Capsules, MediCabilis CBD oil, and others.
- On April 2023, Aelis Farma announced a study of phase 2 clinical trails for AEF0117. The safety and tolerability of AE0117 has been demonstrated in the clinical studies conducted to date. This study will provide additional data on the efficacy of AEF0117 on treatment-seeking subjects with moderate to severe CUD.
- On June 2023, PleoPharma Inc. announced a study of phase 2 clinical trials for Gabapentin and Nabilone. This study will be a randomized, double-blind, placebo-controlled, multicenter trial conducted to evaluate whether PP-01 mitigates the withdrawal symptoms associated with discontinuing cannabis in participants with moderate to severe Cannabis Use Disorder (CUD). The study will enroll approximately 225 participants with moderate to severe CUD and will include 5 arms, including a placebo arm, to help assess the incidence and severity of withdrawal symptoms in heavy long-term users of cannabis. Participants receive study medication for 34 days and participate in 11 visits (7 at a clinic and 4 telemedicine).
Discover more about therapies set to grab major Cannabis Use Disorder Market Share @ Cannabis Use Disorder Market Size
Cannabis Use Disorder Overview
Cannabis (also called marijuana) is the third most commonly used psychoactive substance worldwide, after alcohol and tobacco (nicotine). Cannabis can be administered by various methods including smoking, vaping, dabbing, ingesting (edibles, beverages, and tinctures), and topical cream. Cannabis use disorder develops in approximately 10% of regular cannabis users and up to 50% of chronic daily users and may be associated with cognitive impairment, poor school or work performance, and psychiatric comorbidity such as mood disorders and psychosis.
Cannabis Use Disorder Epidemiology Segmentation in the 7MM
- Total Cannabis Use Disorder Prevalent Cases
- Cannabis Use Disorder Age-Specific Cases
- Cannabis Use Disorder Gender-Specific Cases
Download the report to understand which factors are driving Cannabis Use Disorder Epidemiology Trends @ Cannabis Use Disorder Epidemiological Insights
Cannabis Use Disorder Market Growth
The Market Value of Cannabis Use Disorder is forecasted to steadily grow from XX in 2019 to XX in 2032. The increasing prevalence of Cannabis Use Disorder in almost all 7MM, new upcoming novel therapies and regulatory programs to fasten lab-to-market process are projected to propel the market growth during the forecast period.
Cannabis Use Disorder Market Size
The Cannabis Use Disorder market size is likely to grow during the forecast period owing to the increasing prevalence of Cannabis use disorder among youth, boosted by legalization of cannabis use in many geographies, steps by governments to stop drug abuse.
To know more about Cannabis Use Disorder Treatment options, visit @ Cannabis Use Disorder Drugs
Cannabis Use Disorder Market Dynamics
Cannabis Use Disorder market dynamics is expected to change due to increasing prevalence of Cannabis Use Disorder leading to the development of novel pharmacologic interventions during the forecast period of 2023─2032. Companies are persistently working towards the development of new treatment therapies and some of the key players at the global level are Indivior, among others.
Cannabis Use Disorder Market Outlook
The Cannabis Use Disorder market outlook is a subject of growing importance in the healthcare industry. With the changing legal landscape and increasing acceptance of cannabis for medicinal and recreational purposes, concerns about the potential for misuse and addiction have come to the forefront. Cannabis Use Disorder refers to a pattern of problematic cannabis use leading to significant impairment or distress. As the prevalence of cannabis use rises, so does the need for effective treatments and interventions for individuals struggling with CUD.
The Cannabis Use Disorder market outlook is likely to witness considerable growth in the coming years as pharmaceutical companies and research organizations invest in developing innovative therapies and solutions to address this public health concern. Moreover, healthcare providers will play a pivotal role in identifying and treating individuals with CUD, leading to increased demand for specialized support services and treatment facilities. As efforts continue to raise awareness about the risks associated with excessive cannabis use and the importance of early intervention, the CUD market outlook is expected to evolve significantly to meet the emerging challenges and opportunities.
Learn more about the Cannabis Use Disorder Pipeline Therapies in clinical trials @ Cannabis Use Disorder Market Landscape
Scope of the Cannabis Use Disorder Pipeline Report
- Coverage- 7MM
- Cannabis Use Disorder Companies- Indivior, Aelis Farma, PleoPharma Inc., Tilray, Fenix Innovation Group, Neurotech International, BrosMed Medical Co. Ltd., Klein Buendel Inc., and others.
- Cannabis Use Disorder Pipeline Therapies- AEF0117, FEN164, Brexpiprazole, MediCabilis CBD Oil, Cannabidiol (CBD) Oil Capsules, MediCabilis CBD oil, and others.
- Cannabis Use Disorder Market Dynamics: Cannabis Use Disorder Market Drivers and Barriers
- Cannabis Use Disorder Market Access and Reimbursement, Unmet Needs, Analyst Views
Discover more about Cannabis Use Disorder Drugs in development @ Cannabis Use Disorder Ongoing Clinical Trials Analysis
Table of Content
- Key Insights
- Executive Summary of Cannabis Use Disorder
- Competitive Intelligence Analysis for Cannabis Use Disorder
- Cannabis Use Disorder: Market Overview at a Glance
- Cannabis Use Disorder: Disease Background and Overview
- Patient Journey
- Cannabis Use Disorder Epidemiology and Patient Population
- Treatment Algorithm, Current Treatment, and Medical Practices
- Unmet Needs
- Key Endpoints of Cannabis Use Disorder Treatment
- Marketed Products
- Emerging Therapies
- Cannabis Use Disorder: Seven Major Market Analysis
- Attribute analysis
- 7MM: Market Outlook
- Access and Reimbursement Overview of Cannabis Use Disorder
- KOL Views
- Cannabis Use Disorder Market Drivers
- Cannabis Use Disorder Market Barriers
- DelveInsight Capabilities
- About DelveInsight
Get in touch with our Business executive @ Cannabis Use Disorder Market Drivers and Barriers
List of Top Selling Market Research Reports in 2023
Lhon Market | Fibrocystic Breast Condiion Market | Chronic Gout Market | Acral Lentiginous Melanoma Market | Concussions Market Size | Familial Primary Pulmonary Hypertension Market | Hpv-induced Cancers Market | Malt Lymphoma Market | Polycythemia Market | Ventilator Market | X Linked Hypophosphatemia Market | Wound Closure Devices Market | Vitamin A Deficiency Market | Vertigo Market | Vascular Access Devices Market | Upper Limb Hypertonia Market | Triple Negative Breast Cancer Market | Thymic Carcinoma Market | Thrombocytopenia Market | Surgical Site Infection Ssi Market | Spasticity Market | Severe Hypoglycemia Market | Scleroderma Market | Radiation Toxicity Market | Pulse Oximeters Market | Pruritus Market | Prader-willi Syndrome Market | Post Traumatic Stress Disorder Market | Pediatric Obesity Market | Palmar Hyperhidrosis Market Size | Pain Management Devices Market | Osteochondromas Market | Osteoarthritis Market | Oral Mucositis Om Market | Opioid Induced Constipation Market | Ophthalmic Imaging Equipment Market | Onycholysis Market | Ncfb Market | Neurovascular Devices Market | Neurostimulation Devices Market | Neuromodulation Devices Market | Neurofibromatosis 2 Market | Neuroblastoma Market | Necrotizing Enterocolitis Market | Metachromatic Leukodystrophy Market Research Report | Kidney Transplant Rejection Market | Juvenile Rheumatoid Arthritis Market | Implantable Infusion Pumps Market | Immunologic Deficiency Syndrome Market | Image Guided Surgery Devices Market | Hypothalamic Obesity Market | Hypoparathyroidism Market | Hyperuricemia Market | Hyperhidrosis Market |Hereditary Spastic Paraplegias Market | Hemophilia B Market | Hemodynamic Monitoring Systems Market | Hearing Implants Market | Foot And Ankle Devices Market | Epilepsy Market | Global Electrophysiology Devices Market | Ehlers-danlos Syndrome Market | Dlbcl Market | Diffuse Large B-cell Lymphoma Market | Dermal Mycosis Market
Read More about Consulting Services:
Biotech Consulting | Business Consulting Services | Consulting Services | Healthcare Business Development | Healthcare Consulting Services | Healthcare Strategy Consulting | Life Science Consulting | Life Science Consulting Firms
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Healthcare Market Research Reports, Competitive Landscaping, and Mergers & Acquisitions.